Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSUTINIB vs BREO ELLIPTA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSUTINIB vs BREO ELLIPTA: Safety Overview

Metric BOSUTINIB BREO ELLIPTA
Total FAERS Reports 7,777 218
Deaths Reported 680 1
Death Rate 8.7% 0.5%
Hospitalizations 1,675 20
Average Patient Age 64.7 yrs 70.0 yrs
% Female Patients 51.8% N/A
FDA Approval Date May 23, 2025 N/A
Manufacturer U.S. Pharmaceuticals N/A
Route ORAL N/A
Marketing Status Prescription N/A